Litcius/Paper detail

Establishment of the LNCaP Cell Line – The Dawn of an Era for Prostate Cancer Research

Cory Abate-Shen, Francisca Nunes de Almeida

2022Cancer Research42 citationsDOIOpen Access PDF

Abstract

Among the relatively few established human prostate cancer cell lines, LNCaP cells are unique in their ability to model key stages of prostate cancer progression. Analyses of LNCaP cells and their derivatives have been invaluable for elucidating important translational aspects of prostate tumorigenesis, metastasis, and drug response, particularly in the context of androgen receptor signaling. Here, we present major highlights from a wealth of literature that has exploited LNCaP cells and their derivatives to inform on prostate cancer progression and androgen response for improving the treatment of patients with prostate cancer. See related article by Horoszewicz and colleagues, Cancer Res 1983;43:1809-18.

Topics & Concepts

LNCaPProstate cancerMedicineOncologyAndrogen receptorInternal medicineProstateCancer researchContext (archaeology)CancerAndrogenClinical trialCellCancer cellTranslational researchCancer cell linesCell cultureProstate Cancer Treatment and ResearchCancer Cells and MetastasisHippo pathway signaling and YAP/TAZ